Latest from Healthcare

Deal flow: Albion Ventures has identified the healthcare sector as a growth arena

Albion Ventures adds to healthcare portfolio by backing MyMeds&Me

Investment firm Albion Ventures has added MyMeds&Me to its portfolio through a £2 million transaction.

Medicinal benefits: LumbaCurve is developing treatments for back pain

The North West Fund for Biomedical moves past £10 million mark with LumbaCurve backing

A £125,000 equity investment allocation has been secured by LumbaCurve International to aid in its efforts to conduct market development and a clinical effectiveness study for its lower back pain treatment.

Medicinal value: Algae Health MD Edward McHugh displays the product

Irish biotech firm Algae Health nets funding to target exporting

An investment of €1 million (£854,000) is set to allow biotech business Algae Health to recruit an extra 23 people in the coming three years.

Medical innovation: Asalus technology is aimed at laparoscopic surgery

Third fundraising round for Asalus Medical Instruments as it targets product launch

Asalus Medical Instruments has raised £1.25 million ahead of the launch of its Ultravision technology in the second half of 2013.

Technology enabled: Med ePad's tablet is for use by hospital professionals

Med ePad secures new chairman and chief executive alongside funding round

An equity investment of £150,000 has been netted by healthcare technology business Med ePad.

Expanding footprint: Horizon Care now has 34 homes and 7 schools

Buy and build acquisition for specialist healthcare business Horizon Care

NGBI Private Equity portfolio business Horizon Care has made a bolt-on acquisition with the help of its backer.

Social care: Compass is a fostering agency and is involved with local authorities

August Equity adds Compass to social care portfolio

Private equity firm August Equity has landed its first investment of 2013 by acquiring a stake in Compass Services for Children Group.

Deal team: L-R Robert Milnes, Mohammed Aslam, Julie Newman, Robert Bernays

Fertility test business nets return investment from Midven's Exceed Fund

A seven-figure investment has been secured by Fertility Focus from a group of backers including Midven's Exceed Fund and the Angel CoFund.

Lamellar Biomedical gets £3.3 million capital injection to develop treatments

A Scottish biomedical company has received the support of a number of equity backers as it looks to continue with the commercialisation of its products.

Life sciences: The firm works with pharma, biotech and medical device companies

ISDX to AIM move for Venn Life Sciences

Venn Life Sciences has joined the Alternative Investment Market and raised growth funds to support the move.

Biotech: EpiStem has adult epitherial stem cell expertise in onthology diseases

New AIM placing for EpiStem to aid with development of Genedrive diagnostic

EpiStem, a biotechnology and personalised medicine company, has used its Alternative Investment Market listing to raise £4.3 million. 

Quitting time: TTS Pharma's treatment helps create tailored doses of nicotine

Nicotine supplement company TTS Pharma to locate to North West following SPARK Impact-led investment

Personalised nicotine patch business TTS Pharma has received investment from regional backer The North West Fund for Biomedical.

Biomedical research: The £39 million follows on from £10 million in August

David Cameron’s Biomedical Catalyst provides £39 million outlay to SMEs and universities

The government's Biomedical Catalyst is set to plough £39 million into the healthcare sector as part of its latest allocation.

Waiting room: Qinec provides tools to automate clinical administration

Amadeus and Archimedia support Qinec’s goal to ‘empower’ clinicians

An equity investment of £1.6 million is set to allow Qinec to expand its management team and develop its product portfolio.

Biotech growth: Ziarco has now secured the backing of a major pharmaceuticals firm

Kent biotech firm Ziarco secures Pfizer as backer and collects £3.75 million

UK-based biotech start-up Ziarco has closed the first tranche of what it reveals will be a £16.8 million Series A funding round.

Waiting time: Zilico's technology is said to speed up diagnosis findings

Top-up funding for Zilico from SPARK as it targets 2013 cancer product launch

Zilico has added to the £1 million investment it netted in June 2012 by securing a further £750,000.

Skin care: Dermatology is the bed rock of Alliance Pharma's activity

Alliance Pharma continues down acquisition path by adding Opus to its operations

AIM-listed Alliance Pharma has closed its second acquisition of 2012 through the purchase of Opus Group.

Domiciliary care: Enara has fuelled its recent growth with bolt-on deals

Enara sold to MITIE by August Equity after completing 50 acquisitions in four years

August Equity has sold portfolio company Enara having led the business through a buy-and-build growth strategy since 2008.

In the chair: Calcivis' technology is said to detect early stage tooth decay

Calcivis attracts host of angel backers from Archangels to continue dental development

A newly-formed Scottish biotech company has secured the backing it needs to develop its tooth decay assessment technology.

Lung conditions: BiOxyDen is said to help with afflictions such as asthma

Landmark deal for North West Fund for Biomedical

A 25th investment for the North West Fund for Biomedical has seen BiOxyDyn secure the funds it needs to grow.

More from GrowthBusiness

The Entrepreneur

Global growth: SABMiller has helped out in places including Cape Town

Fostering global entrepreneurial communities through finance and mentorship

With its commercial activities taking it into many countries and communities around the world, brewery company SABMiller is supporting entrepreneurs to build their own enterprises.

Growing A Business

Nightmares: Business conference venues and how to sleep more easily

Jude Harrison, SEO account manager at Steak Group, recalls his business conference nightmares and advises on how to avoid the same pitfalls.

Comment & Analysis

Crowdfunding: An arriving and welcome phenomenon

The rise of crowdfunding can only be sustained if we keep the nanny state out.

Research

Source of growth: There are 64 UK-listed cash shells holding £237.9 million

The rise of cash shells

New research from GrowthBusiness shows that the number of UK cash shells is climbing. We speak to new entrants to the market and those that have recently closed deals to find out what’s driving shells’ increasing popularity.